undamentalytics Newsletter
Sign in

Cytosorbents Corp balance sheet

At the end of fiscal 2025, Cytosorbents Corp had total assets of $44.2m, total liabilities of $38.3m and shareholders' equity of $5.9m. It held $6.2m in cash against $18.4m of debt: net debt of $12.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents12245517221271522214364
Receivables0——1112445566787
Inventory0101111123533354
Total current assets233810821282182643425222116
Total assets2348111024342790906353474438
Accounts payable1111111122324332
Deferred revenue (current)——000—0001221101
Total current liabilities223534871010141014101024
Short-term debt————014120——3——14
Long-term debt0———0469130—5314173
Total debt1120051010150055141818
Total liabilities223—3814172411272829363839
Shareholders' equity−10−12−1471011017379633523116−1
Non-controlling interests and other (assets − liabilities − equity)101315—−2———————————
Net debt (negative = net cash)−1−1−1−4−5−0−7−123−71−52−17−9111214
Shares outstanding——10m—25m25m29m32m33m43m44m44m54m55m63m63m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CTSO vs ECORCTSO vs UTMDCTSO vs RVP

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cytosorbents Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cytosorbents Corp.